Japanese
Management Philosophy
We will contribute to the health and welfare of people throughout the world by providing advanced in vitro diagnostics and medical instruments based on scientific and technological advances.
Press Releases
- September 28, 2012
- Kyowa Medex to sponsor, WEO Colorectal Cancer Screening Committee UEG Week 2012 Workshop at Amsterdam
- May 7, 2012
- Kyowa Medex Launched POTELIGEO® TEST IHC and POTELIGEO® TEST FCM,Companion Diagnostics of POTELIGEO® Injection in Japan
- March 30, 2012
- Kyowa Medex Receives Approval for POTELIGEO TEST IHC and POTELIGEO TEST FCM, Companion Diagnostics of POTELIGEO Injection in Japan
- October 1, 2011
- Kyowa Medex to exhibit at MEDICA -2011, - Messe Dusseldorf, Germany, Nov. 16 - 19, 2011
- September 1, 2011
- Establishment of Kyowa Medex (Shanghai) Co., Ltd. as Import and Sales Company in Rapidly Expanding China.
- May 10, 2011
- New in vitro diagnostic reagents and analyzer for various allergens Launch announcement for Allerport HRT and its dedicated analyzer, Allerport HRT System
- April 26, 2011
- Kyowa Medex Submitted New Drug Application for In Vitro Diagnostic Reagent to Detect CCR4 Proteins in Japan
- April 20, 2011
- Kyowa Medex forms a joint business with Toyobo, for fully automated gene analysis system GENECUBE
- April 1, 2011
- New fully automated fecal occult blood test analyzer Launch announcement for HM-JACKarc system (International version)
